Cell Source Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 1
Employees
  • Stock Symbol
  • CLCS
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $1.47
  • (As of Friday Closing)

Cell Source General Information

Description

Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. Its other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched and mismatched organ transplantation.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PINX
Primary Office
  • 57 West 57th Street
  • Suite 400
  • New York, NY 10019
  • United States
+1 (646) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cell Source Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.47 $1.49 $0.80 - $2.55 $50M 33.5M 3.25K -$0.21

Cell Source Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 69,491 67,748 31,213 22,301
Revenue 0 0 0 0
EBITDA (3,987) (3,623) (4,168) (1,639)
Net Income (5,420) (4,560) (4,475) (2,117)
Total Assets 309 452 115 66
Total Debt 6,874 4,806 2,598 2,673
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cell Source Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cell Source‘s full profile, request access.

Request a free trial

Cell Source Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The c
Biotechnology
New York, NY
1 As of 2020
0000

00000000

m ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat
0000000000000
Paris, France
000 As of 0000
00000
00000000 00000

000000 0

oluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pr
000000000000000
Foster City, CA
00000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cell Source Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellectis Formerly VC-backed Paris, France 000 00000 00000000 00000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
0000000 Formerly VC-backed Summit, NJ 0000 000.00 000000&0 000.00
00000000 Corporation Basel, Switzerland 000000 000000000000
00000000 Private Equity-Backed Seoul, South Korea 000 00 000000
You’re viewing 5 of 7 competitors. Get the full list »

Cell Source Executive Team (1)

Name Title Board Seat Contact Info
Itamar Shimrat Chief Executive Officer & Chief Financial Officer, Finance
To view Cell Source’s complete executive team members history, request access »

Cell Source Board Members (2)

Name Representing Role Since
000000 00000 00.0 Self Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Cell Source Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cell Source Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cell Source‘s full profile, request access.

Request a free trial

Cell Source Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000 (00000 01-Jul-2014 000000000000000000 Biotechnology
To view Cell Source’s complete acquisitions history, request access »